Wednesday, November 4, 2009
Monday, October 5, 2009
Ten Swine Flu Lies Told by MSM
(NaturalNews) The mainstream media is engaged in what we Americans call “bald faced lies” about swine flu. It seems to be true with this issue more than any other, and it became apparent to me recently when a colleague of mine — a nationally-syndicated newspaper columnist — told me their column on natural defenses for swine flu was rejected by newspapers all across the country. Many newspapers refused to run the column and, instead, ran an ad for “free vaccine clinics” in the same space.
The media, it seems, is so deeply in bed with the culture of vaccinations that they will do almost anything to keep the public misinformed. And that includes lying about swine flu vaccines.
There are ten key lies that continue to be told by the mainstream media (MSM) about swine flu and swine flu vaccines.
Lie #1 - There are no adjuvants used in the vaccines
I was recently being interviewed by a major U.S. news network when the reporter interviewing me came up with this humdinger: There are no adjuvants being used in the swine flu vaccines, he said!
I assured him that adjuvants were, indeed, a crucial part of the vaccine recipe, and they were being widely used by drug companies to “stretch” the vaccine supply. It’s no secret. But he insisted he had been directly told by a drug company rep that no adjuvants were being used at all. And he believed them! So everything being published by this large news network about swine flu vaccines now assumes there are no adjuvants in the vaccines at all.
Lie #2 - The swine flu is more dangerous than seasonal flu
This lie is finally starting to unravel. I admit that in the early days of this pandemic, even I was concerned this could be a global killer. But after observing the very mild impact the virus was having on people in the real world, it became obvious that this was a mild flu, no more dangerous than a seasonal flu. The MSM, however, continues to promote H1N1 swine flu as being super dangerous, driving fear into the minds of people and encouraging them to rush out and get a vaccine shot for a flu that’s really no more likely to kill them than the regular winter sniffles. Sure, the virus could still mutate into something far worse, but if it does that, the current vaccine could be rendered obsolete anyway!
Lie #3 - Vaccines protect you from swine flu
This is the biggest lie of all, and the media pushes it hard. Getting a vaccine, they insist, will protect you from the swine flu. But it’s just flat-out false. Even if the vaccine produces antibodies, that’s not the same thing as real-world immunity from a live virus, especially if the virus mutates (as they often do). As I pointed out in a recent article, statistically speaking the average American is 40 times more likely to be struck by lightning than to have their life saved by a swine flu vaccine. (http://www.naturalnews.com/026955_s…)
Lie #4 - Vaccines are safe
And how would any journalists actually know this? None of the vaccines have been subjected to real-world testing for any meaningful duration. The “safety” of these vaccines is nothing more than wishful thinking. The MSM also doesn’t want you to know what’s in the vaccines. Some vaccines are made from viral fragments grown in diseased African monkeys. If that sounds incredible, read the true story here: http://www.naturalnews.com/026779_s…
Lie #5 - The vaccine isn’t mandatory
You hear this lie all the time: The swine flu vaccine shot is voluntary, they say. But it’s not true if you’re an employee at a place where vaccines are being mandated. Millions of Americans are now being told by their employers that if they don’t get vaccine shots, they will be effectively fired from their jobs. It’s especially true with health care workers, day care employees and school teachers.
Lie #6 - Getting a vaccine shot is a good bet on your health
In reality, a vaccine shot is far more likely to harm you than help you. According to one viral expert, the actual mortality rate of the swine flu virus is estimated to be as low as .007 percent (http://www.reuters.com/article/heal…). That means H1N1 swine flu kills less than one person in 100,000. Even if the vaccine works, let’s say, 10 percent of the time, you’d have to vaccine one million people to prevent one death from swine flu. And in vaccinating one million people, you would inevitably harm or kill several people, simply from the vaccine side effects! Your net risk of death is increased by getting a swine flu vaccine.
Lie #7 - The vaccine isn’t made with “attenuated live virus”
When the swine flu vaccines were first being announced several months ago, they were described as being made with “attenuated live virus.” This was directly mentioned in CDC documents, among other places. This term apparently freaked out the American news consumer, and it has since been all but erased from any discussion about vaccines. Now, journalists will actually argue with you and insist the vaccines contain no attenuated live viruses whatsoever. Except they’re wrong. The vaccines are, indeed, made with “attenuated live viruses.” That’s how you make a vaccine: You take live viruses, then you weaken them (”attenuate”) and inject them into people.
Lie #8 - Wash, wash, wash your hands (to avoid exposure)
This idea of washing your hands a hundred times a day is all based on the assumption that you can avoid exposure to the swine flu virus. But that’s impractical. The virus is now so widespread that virtually everyone is certain to be exposed to it through the air if not other means. This whole idea of avoiding exposure to the swine flu virus is nonsense. The conversation should shift to ways to survive exposure via a healthy immune system. Of course, hand washing is a very good idea in a hospital setting. Recent news reveals that doctors are too busy to wash their own hands, resulting in the rampant spread of superbugs throughout most large hospitals in first world nations.
Lie #9 - Children are more vulnerable to swine flu than adults
This is just a flat-out lie, but it makes for good vaccine sales. Vaccines are right now being targeted primarily to schoolchildren. But the truth is that swine flu is extremely mild in children. “It’s mildest in kids,” says Dr Marc Lipsitch of Harvard University. “That’s one of the really good pieces of news in this pandemic.” Reuters actually had the guts to report this story, but most of the larger media outlets are still reporting that children are the most vulnerable.
Lie #10 - There is nothing else you can do beyond a vaccine and Tamiflu
This is where the media lies by omission. The mainstream media absolutely refuses to print just about any story that talks about using vitamin D, anti-viral herbs or natural remedies to protect yourself from swine flu. In the MSM, there are two options and only two: Vaccines and Tamiflu. That’s it. No other options exist in their fictional reality.
Why is the mainstream media so afraid to print the truth these days? Why can’t reporting on swine flu see the light of day… literally, with a mention of sunlight and vitamin D? Apparently, Big Pharma has such a tight grip on mainstream newspapers that no true story on swine flu can ever make it past the editor’s desk.
Killing stories, deceiving the public
It must really be depressing to work for the mainstream media. Even the reporters I know can’t stand it. The truth, they admit, rarely makes it into print.
Over the last few years, I’ve had a couple of job offers from large media outlets. They want to pay me a six-figure salary and stick me behind a desk where they can control what I report. Needless to say, I routinely reject those offers. If I can’t write the truth like I do here on NaturalNews.com, there’s no point writing at all. In too many ways, the mainstream media has become little more than a corporate mouthpiece, whoring itself out to the highest bidder / advertiser.
It’s no fault of the frontline reporters who actually work there. For the most part, they agree with what I’m saying. It’s the fault of the profit-oriented corporate mindset where news is about selling newspapers rather than actually informing the public.
Important news stories get killed every day in the newsrooms across America. They get killed not because they are poorly investigated or poorly written, but because they upset advertisers and corporate string pullers who shape the news and reject any stories that threaten their own financial interests.
Here in 2009, the distorted reporting on the swine flu vaccine has been one of the greatest media frauds ever perpetrated. The media has in every way contributed to the widespread ignorance of the American people on the subject of vitamin D and natural immune-boosting defenses that could reduce swine flu fatalities. Rather than informing readers, the MSM has made it a point to keep the people stupid, and in doing so, the media has failed its only mission and betrayed the very audience is claims to serve.
www.naturalnews.com/027055_swine_flu_vaccines_swine_flu_vaccine.html
Saturday, October 3, 2009
What's in YOUR Vaccine?
VACCINE INGREDIENTS
The questions: "What is in the flu shot and what is in the vaccinations they are giving my child?", are being raised by those that are taking responsibility for their health and that of their loved ones. This brings hope that, one day soon, parents will have the truth and be able to make more logical decisions in the future. ~ Vickie Barker
a representative sample | |||||
|---|---|---|---|---|---|
| Vaccine | Manufacturer | Microbes | Antibiotics | Chemicals / Heavy Metals | Animal ByProducts |
| Acel-Immune DTaP diphtheria - tetanus - pertussis | Wyeth-Ayerst 800.934.5556 | diphtheria and tetanus toxoids and acellular pertussis adsorbed | | formaldehyde, aluminum hydroxide, aluminum phosphate, thimerosal, and polysorbate 80 (Tween-80) | gelatin |
| Act HIB Haemophilus influenza Type B | Connaught Laboratories 800.822.2463 | Haemophilus influenza Type B, polyribosylribitol phosphate | | ammonium sulfate, formalin, and sucrose | |
| Attenuvax measles | Merck & Co., Inc. 800-672-6372 | measles live virus | neomycin | sorbitol | hydrolized gelatin, chick embryo |
| Biavax rubella | Merck & Co., Inc. 800-672-6372 | rubella live virus | neomycin | sorbitol | hydrolized gelatin, human diploid cells from aborted fetal tissue |
| BioThrax anthrax adsorbed | BioPort Corporation 517.327.1500 | nonencapsulated strain of Bacillus anthracis | | aluminum hydroxide, benzethonium chloride, and formaldehyde | |
| DPT diphtheria - tetanus - pertussis | GlaxoSmithKline X 5231 800.366.8900 | diphtheria and tetanus toxoids and acellular pertussis adsorbed | | formaldehyde, aluminum phosphate, ammonium sulfate, and thimerosal | washed sheep RBCs |
| Dryvax smallpox (not licensed d/t expiration) | Wyeth-Ayerst 800.934.5556 | live vaccinia virus, with "some microbial contaminants," according to the Working Group on Civilian Biodefense | polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate | glycerin, and phenol -a compound obtained by distillation of coal tar | vesicle fluid from calf skins |
| Engerix-B recombinant hepatitis B | GlaxoSmithKline X 5231 800.366.8900 | genetic sequence of the hepatitis B virus that codes for the surface antigen (HbSAg), cloned into GMO yeast | | aluminum hydroxide, and thimerosal | |
| Fluvirin | Medeva Pharmaceuticals 888.MEDEVA 716.274.5300 | influenza virus | neomycin, polymyxin | beta-propiolactone | chick embryonic fluid |
| FluShield | Wyeth-Ayerst 800.934.5556 | trivalent influenza virus, types A&B | gentamicin sulphate | formadehyde, thimerosal, and polysorbate 80 (Tween-80) | chick embryonic fluid |
| Havrix hepatitis A | GlaxoSmithKline X 5231 800.366.8900 | hepatitis A virus | | formalin, aluminum hydroxide, 2-phenoxyethanol, and polysorbate 20 | residual MRC5 proteins -human diploid cells from aborted fetal tissue |
| HiB Titer Haemophilus influenza Type B | Wyeth-Ayerst 800.934.5556 | Haemophilus influenza Type B, polyribosylribitol phosphate, yeast | | ammonium sulfate, thimerosal, and chemically defined yeast-based medium | |
| Imovax | Connaught Laboratories 800.822.2463 | rabies virus adsorbed | neomycin sulfate | phenol red indicator | human albumin, human diploid cells from aborted fetal tissue |
| IPOL | Connaught Laboratories 800.822.2463 | 3 types of polio viruses | neomycin, streptomycin, and polymyxin B | formaldehyde, and 2-phenoxyethenol | continuous line of monkey kidney cells |
| JE-VAX Japanese encephalitis | Aventis Pasteur USA 800.VACCINE | Nakayama-NIH strain of Japanese encephalitis virus, inactivated | | formaldehyde, polysorbate 80 (Tween-80), and thimerosal | mouse serum proteins, and gelatin |
| LYMErix lyme | GlaxoSmithKline 888-825-5249 | recombinant protein (OspA) from the outer surface of the spirochete Borrelia burgdorferi | kanamycin | aluminum hydroxide, 2-phenoxyethenol, phosphate buffered saline | |
| MMR measles - mumps - rubella | Merck & Co., Inc. 800.672.6372 | measles, mumps, rubella live virus | neomycin | sorbitol | hydrolized gelatin, chick embryonic fluid, and human diploid cells from aborted fetal tissue |
| M-R-Vax measles - rubella | Merck & Co., Inc. 800.672.6372 | measles, rubella live virus | neomycin | sorbitol | hydrolized gelatin, chick embryonic fluid, and human diploid cells from aborted fetal tissue |
| Menomune meningococcal | Connaught Laboratories 800.822.2463 | freeze-dried polysaccharide antigens from Neisseria meningitidis bacteria | | thimerosal | lactose |
| Meruvax I mumps | Merck & Co., Inc. 800.672.6372 | mumps live virus | neomycin | sorbitol | hydrolized gelatin |
| NYVAC (new smallpox batch, not licensed) | Aventis Pasteur USA 800.VACCINE | highly attenuated vaccinia virus | polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate | glycerin, and phenol -a compound obtained by distillation of coal tar | vesicle fluid from calf skins |
| Orimune oral polio | Wyeth-Ayerst 800.934.5556 | 3 types of polio viruses, attenuated | neomycin, streptomycin | sorbitol | monkey kidney cells and calf serum |
| Pneumovax Streptococcus pneumoniae | Merck & Co., Inc. 800.672.6372 | capsular polysaccharides from polyvalent (23 types) pneumococcal bacteria | | phenol | |
| Prevnar Pneumococcal 7-valent conjugate vaccine | Wyeth Lederle 800.934.5556 | saccharides from capsular Streptococcus pneumoniae antigens (7 serotypes) individually conjugated to diphtheria CRM 197 protein | | aluminum phosphate, ammonium sulfate, soy protein, yeast | |
| ProQuad measles, mumps, rubella and varicella | Merck & Co., Inc. 800.672.6372 | live measles (Enders' attenuated Edmonston), mumps (Jeryl LynnTM), rubella (Wistar RA 27/3), and varicella (oka/Merck) strains of viruses | neomycin | monosodium L-glutamate (MSG), potassium chloride, potassium phosphate monobasic, potassium phosphate dibasic, sodium bicarbonate, sodium phosphate dibasic, sorbitol, and sucrose | human albumin, human diploid cells, residual components of MRC-5 cells including DNA and proteins, bovine serum, hydrolized gelatin, and chicken embryo |
| RabAvert rabies | Chiron Behring GmbH & Company 510.655.8729 | fixed-virus strain Flury LEP | neomycin, chlortetracycline, and amphotericin B | potassium glutamate, and sucrose | human albumin, bovine gelatin and serum "from source countries known to be free of bovine spongioform encephalopathy," and chicken protein |
| Rabies Vaccine Adsorbed | GlaxoSmithKline X 5231 800.366.8900 | rabies virus adsorbed | | beta-propiolactone, aluminum phosphate, thimerosal, and phenol red | rhesus monkey fetal lung cells |
| Recombivax recombinant hepatitis B | Merck & Co., Inc. 800.672.6372 | genetic sequence of the hepatitis B virus that codes for the surface antigen (HbSAg), cloned into GMO yeast | | aluminum hydroxide, and thimerosal | |
| RotaShield oral tetravalent rotavirus (recalled) | Wyeth-Ayerst 800.934.5556 | 1 rhesus monkey rotavirus, 3 rhesus-human reassortant live viruses | neomycin sulfate, amphotericin B | potassium monophosphate, potassium diphosphate, sucrose, and monosodium glutamate (MSG) | rhesus monkey fetal diploid cells, and bovine fetal serum |
| smallpox (not licensed due to expiration) 40-yr old stuff "found" in Swiftwater, PA freezer | Aventis Pasteur USA 800.VACCINE | live vaccinia virus, with "some microbial contaminants," according to the Working Group on Civilian Biodefense | polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate | glycerin, and phenol -a compound obtained by distillation of coal tar | vesicle fluid from calf skins |
| smallpox (new, not licensed) | Acambis, Inc. 617.494.1339 in partnership with Baxter BioScience | highly attenuated vaccinia virus | polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate | glycerin, and phenol -a compound obtained by distillation of coal tar | vesicle fluid from calf skins |
| TheraCys BCG (intravesicle -not licensed in US for tuberculosis) | Aventis Pasteur USA USA 800.VACCINE | live attenuated strain of Mycobacterium bovis | | monosodium glutamate (MSG), and polysorbate 80 (Tween-80) | |
| Tripedia diphtheria - tetanus - pertussis | Aventis Pasteur USA 800.VACCINE | Corynebacterium diphtheriae and Clostridium tetani toxoids and acellular Bordetella pertussis adsorbed | | aluminum potassium sulfate, formaldehyde, thimerosal, and polysorbate 80 (Tween-80) | gelatin, bovine extract US sourced |
| Typhim Vi typhoid | Aventis Pasteur USA SA 800.VACCINE | cell surface Vi polysaccharide from Salmonella typhi Ty2 strain | | aspartame, phenol, and polydimethylsiloxane (silicone) | |
| Varivax chickenpox | Merck & Co., Inc. 800.672.6372 | varicella live virus | neomycin | phosphate, sucrose, and monosodium glutamate (MSG) | processed gelatin, fetal bovine serum, guinea pig embryo cells, albumin from human blood, and human diploid cells from aborted fetal tissue |
| YF-VAX yellow fever | Aventis Pasteur USA 800.VACCINE | 17D strain of yellow fever virus | | sorbitol | chick embryo, and gelatin |
Do You Know What's Inside a Flu Shot?
Do You Know What's Inside a Flu Shot?
Each year, just as multiple reminders on the need for and efficacy of getting a flu shot hit the news wires, I start receiving a steady stream of e-mails from readers, all asking the same basic question:
"Should I get a flu shot?"
My answer is an unequivocal no. I never recommend getting a flu shot. Based on everything that I know about flu shots, I think it's pretty clear that their main effect is to tax and possibly weaken one's immune system.
Before I highlight my main reasons for saying no to flu shots, please have a look at the following skit by the Royal Canadian Air Farce - it's quite the humorous look at the main ingredients that go into flu shots, and how little the general public knows about what's being injected into their bloodstreams:
There are a number of reasons why I feel that flu shots should be avoided, and almost all of them are related to the ingredients mentioned in this video.
But here's the most glaring reason: One in a million people who get the flu shot develops a neurological disease called Guillain-Barré Syndrome.
Guillain-Barré syndrome tends to develop without notice, and is marked by extreme muscle weakness and other symptoms related to nerve dysfunction. I once provided ongoing chiropractic treatments to a professional athlete who had to retire early because he developed Guillain-Barré Syndrome, so I know firsthand how debilitating this condition can be.
And let's not miss an obvious point: if one in a million people who get the flu shot can develop a devastating neurological condition, how many others who get the flu shot suffer from a number of uncomfortable symptoms that are never properly or accurately diagnosed? It's just not realistic to think that the ingredients in a flu shot can cause severe neurological damage in a small percentage of the population while leaving everyone else completely uninjured.
The truth is, even if the odds were one in 300 million, I would still say no to getting a flu shot - why take any risk of creating serious damage to my body?
The best defense against the flu and the common cold is to live healthfully every day. And if we do develop the flu or a cold, if we give our bodies time to rest and heal, we can cleanse ourselves of our weakest cells. For more information on this topic, please feel free to view the following articles:
Wednesday, September 9, 2009
Tuesday, August 4, 2009
1. Squalene: The Swine Flu Vaccine’s Dirty Little Secret Exposed

By Dr. Mercola
According to Kathleen Sebelius, Secretary of the U.S. Department of Health and Human Services, your children should be the first target for mass swine flu vaccinations when school starts this fall.[i]This is a ridiculous assumption for many reasons, not to mention extremely high risk.
In Australia, where the winter season has begun, Federal Health Minister Nicola Roxon is reassuring parents the swine flu is no more dangerous than regular seasonal flu. "Most people, including children, will experience very mild symptoms and recover without any medical intervention," she said.[ii]
Sydney-based immunization specialist Robert Booy predicts swine flu might be fatal to about twice as many children in the coming year as regular influenza. Booy estimates 10-12 children could die from the H1N1 virus, compared with the five or six regular flu deaths seen among children in an average year in Australia.[iii]
“Cure the Disease, Kill the Patient”
Less than 100 children in the U.S. die each year from seasonal flu viruses.[iv] If we use Australia’s math, a very rough estimate would be another 100 children could potentially die of swine flu in the United States in the coming year.
If children are the first target group in the U.S. per Sebelius, that means we’re about to inject around 75 million children with a fast tracked vaccine containing novel adjuvants, including dangerous squalene, to prevent perhaps 100 deaths.
I’m not overlooking the tragedy of the loss of even one child to an illness like the H1N1 flu virus. But there can be no argument that unnecessary mass injection of millions of children with a vaccine containing an adjuvant known to cause a host of debilitating autoimmune diseases is a reckless, dangerous plan.
Why are Vaccinations Dangerous?
The presumed intent of a vaccination is to help you build immunity to potentially harmful organisms that cause illness and disease. However, your body’s immune system is already designed to do this in response to organisms which invade your body naturally.
Most disease-causing organisms enter your body through the mucous membranes of your nose, mouth, pulmonary system or your digestive tract – not through an injection.
These mucous membranes have their own immune system, called the IgA immune system. It is a different system from the one activated when a vaccine is injected into your body.
Your IgA immune system is your body’s first line of defense. Its job is to fight off invading organisms at their entry points, reducing or even eliminating the need for activation of your body’s immune system.
When a virus is injected into your body in a vaccine, and especially when combined with an immune adjuvant like squalene, your IgA immune system is bypassed and your body’s immune system kicks into high gear in response to the vaccination.
Injecting organisms into your body to provoke immunity is contrary to nature, and vaccination carries enormous potential to do serious damage to your health.
And as if Vaccines Weren’t Dangerous Enough on Their Own …
… imagine them turbocharged.
The main ingredient in a vaccine is either killed viruses or live ones that have been attenuated (weakened and made less harmful).
Flu vaccines can also contain a number of chemical toxins, including ethylene glycol (antifreeze), formaldehyde, phenol (carbolic acid) and even antibiotics like Neomycin and streptomycin.
In addition to the viruses and other additives, many vaccines also contain immune adjuvants like aluminum and squalene.
The purpose of an immune adjuvant added to a vaccine is to enhance (turbo charge) your immune response to the vaccination. Adjuvants cause your immune system to overreact to the introduction of the organism you’re being vaccinated against.
Adjuvants are supposed to get the job done faster (but certainly not more safely), which reduces the amount of vaccine required per dose, and the number of doses given per individual.
Less vaccine required per person means more individual doses available for mass vaccination campaigns. Coincidentally, this is exactly the goal of government and the pharmaceutical companies who stand to make millions from their vaccines.
Will There Be Immune Adjuvants in Swine Flu Vaccines?
The U.S. government has contracts with several drug companies to develop and produce swine flu vaccines. At least two of those companies, Novartis and GlaxoSmithKline, are using an adjuvant in their H1N1 vaccines.
The adjuvant? Squalene.
According to Meryl Nass, M.D., an authority on the anthrax vaccine,
“A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”[v]
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries.
Per Dr. Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.
What Squalene Does to Rats
Oil-based vaccination adjuvants like squalene have been proved to generate concentrated, unremitting immune responses over long periods of time.[vi]
A 2000 study published in the American Journal of Pathology demonstrated a single injection of the adjuvant squalene into rats triggered “chronic, immune-mediated joint-specific inflammation,” also known as rheumatoid arthritis.[vii]
The researchers concluded the study raised questions about the role of adjuvants in chronic inflammatory diseases.
What Squalene Does to Humans
Your immune system recognizes squalene as an oil molecule native to your body. It is found throughout your nervous system and brain. In fact, you can consume squalene in olive oil and not only will your immune system recognize it, you will also reap the benefits of its antioxidant properties.
The difference between “good” and “bad” squalene is the route by which it enters your body. Injection is an abnormal route of entry which incites your immune system to attack all the squalene in your body, not just the vaccine adjuvant.
Your immune system will attempt to destroy the molecule wherever it finds it, including in places where it occurs naturally, and where it is vital to the health of your nervous system.[viii]
Gulf War veterans with Gulf War Syndrome (GWS) received anthrax vaccines which contained squalene.[ix] MF59 (the Novartis squalene adjuvant) was an unapproved ingredient in experimental anthrax vaccines and has since been linked to the devastating autoimmune diseases suffered by countless Gulf War vets.[x]
The Department of Defense made every attempt to deny that squalene was indeed an added contaminant in the anthrax vaccine administered to Persian Gulf war military personnel – deployed and non-deployed – as well as participants in the more recent Anthrax Vaccine Immunization Program (AVIP).
However, the FDA discovered the presence of squalene in certain lots of AVIP product. A test was developed to detect anti-squalene antibodies in GWS patients, and a clear link was established between the contaminated product and all the GWS sufferers who had been injected with the vaccine containing squalene.
A study conducted at Tulane Medical School and published in the February 2000 issue of Experimental Molecular Pathology included these stunning statistics:
“ … the substantial majority (95%) of overtly ill deployed GWS patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene.
In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene. Neither patients with idiopathic autoimmune disease nor healthy controls had detectable serum antibodies to squalene. The majority of symptomatic GWS patients had serum antibodies to squalene.”[xi]
According to Dr. Viera Scheibner, Ph.D., a former principle research scientist for the government of Australia:
“… this adjuvant [squalene] contributed to the cascade of reactions called "Gulf War Syndrome," documented in the soldiers involved in the Gulf War.
The symptoms they developed included arthritis, fibromyalgia, lymphadenopathy, rashes, photosensitive rashes, malar rashes, chronic fatigue, chronic headaches, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated ESR (erythrocyte sedimentation rate), systemic lupus erythematosus, multiple sclerosis, ALS (amyotrophic lateral sclerosis), Raynaud’s phenomenon, Sjorgren’s syndrome, chronic diarrhoea, night sweats and low-grade fevers.”[xii]
Post Vaccination Follow-Up Might as Well Be Non-Existent
There is virtually no science to support the safety of vaccine injections on your long-term health or the health of your children. Follow-up studies last on average about two weeks, and look only for glaring injuries and illnesses.
Autoimmune disorders like those seen in Gulf War Syndrome frequently take years to diagnose due to the vagueness of early symptoms. Complaints like headaches, fatigue and chronic aches and pains are symptoms of many different illnesses and diseases.
Don’t hold your breath waiting for vaccine purveyors and proponents to look seriously at the long-term health consequences of their vaccination campaigns.
Saturday, July 25, 2009
Children Who Get Flu Vaccine Have Three Times Risk Of Hospitalization For Flu, Study Suggests
"The concerns that vaccination maybe associated with asthma exacerbations have been disproved with multiple studies in the past, but the vaccine's effectiveness has not been well-established," said Avni Joshi, M.D., of the Mayo Clinic in Rochester, MN. "This study was aimed at evaluating the effectiveness of the TIV in children overall, as well as the children with asthma, to prevent influenza-related hospitalization."
The CDC's Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) recommend annual influenza vaccination for all children aged six months to 18 years. The National Asthma Education and Prevention Program (3rd revision) also recommends annual flu vaccination of asthmatic children older than six months.
In order to determine whether the vaccine was effective in reducing the number of hospitalizations that all children, and especially the ones with asthma, faced over eight consecutive flu seasons, the researchers conducted a cohort study of 263 children who were evaluated at the Mayo Clinic in Minnesota from six months to 18 years of age, each of whom had had laboratory-confirmed influenza between 1996 to 2006. The investigators determined who had and had not received the flu vaccine, their asthma status and who did and did not require hospitalization. Records were reviewed for each subject with influenza-related illness for flu vaccination preceding the illness and hospitalization during that illness.
They found that children who had received the flu vaccine had three times the risk of hospitalization, as compared to children who had not received the vaccine. In asthmatic children, there was a significantly higher risk of hospitalization in subjects who received the TIV, as compared to those who did not (p= 0.006). But no other measured factors—such as insurance plans or severity of asthma—appeared to affect risk of hospitalization.
"While these findings do raise questions about the efficacy of the vaccine, they do not in fact implicate it as a cause of hospitalizations," said Dr. Joshi. "More studies are needed to assess not only the immunogenicity, but also the efficacy of different influenza vaccines in asthmatic subjects."
Sunday, February 15, 2009
Tuesday, October 7, 2008
Immunizations: A Second Opinion
Immunizations: A Second Opinion
by Stephen C. Marini, M.S., Ph.D., D.C.
Originally Printed in: I.C.P.A. Newsletter July/August 1997
The following is an excerpt from a statement presented on June 8, 1995 in Washington, D.C. at the Vaccine Safety Forum of the Institute of Medicine, a branch of the Center for Disease Control (CDC).
There is historic epidemiologic evidence that the incidence and severity of infectious diseases wanes in populations over time, particularly in technologically advanced countries such as the United States, as the human immune system naturally adapts to the challenge.
Especially with regard to the passing on of maternal antibodies to protect newborns and keeping usually mild childhood diseases, such as rubella and chicken pox, out of adult populations where they are more severe, the advantage of permanent immunity gained from natural recovery from infectious disease as children outweighs the artificial, temporary immunity provided by vaccines. Data also suggest that the diseases of childhood are necessary for appropriate development, maturation and function of the individual immune and nervous systems.
Furthermore, progress in the field of Psychoneuroendocrinimmunology has led some researchers to conclude that vaccines in general may not only be impacting negatively on the human immune system, but may also be adversely affecting the neurologic and psychologic development and function of the vaccine recipient. The impact of artificial immunity on immune, neurologic, endocrine, and psychologic systems has not been scientifically elucidated.
There is no credible scientific data to demonstrate that the injection of multiple antigens simultaneously into a baby, particularly a baby under the age of one year, is safe and effective. There is no credible scientific evidence to negate the hypothesis that vaccines cause immediate or delayed damage to the immune and neurological disorders including asthma, learning disabilities, hyperactivity, autism, chronic fatigue syndrome, lupus, diabetes, epilepsy, multiple sclerosis, Guillain-Barre syndrome, and other diseases. There is no assurance that the agency charged with detailing and reporting adverse events following immunizations is not ethically constrained by its conflicting responsibility of promoting a vaccine.....
There is growing public awareness of the significance of alternative measures, such as proper nutrition, exercise, rest positive mental outlook and the maintaining of neurologic integrity, as powerful instruments for immunologic enhancement and defense against disease. There is increasing recognition among health care practitioners that the human body has an innate ability to protect and heal itself when allowed to function optimally without interference.Educational Conduits which target the largest number and widest socio-economic cross-sections of the public should be used to reinforce the concept that wellness is a way of life and can only be achieved by employing preventive health care strategies which enhance, not suppress or interfere with, the natural functioning of the human immune system. In recognition of the need to enhance the innate human immune capacity to resist infectious diseases such as polio, health and wellness advocates of the 21st century support the SANS or NO VACCINE option.
Stephen Marini, M.S., Ph.D., D.C. , member of the ICPA Board of Directors, author of numerous articles on virology and vaccination, prominent speaker for the ICPA Chiropractic Pediatric Certification program, former Immunohematologist //Senior Medical Technologist, currently enjoying a successful chiropractic practice in King of Prussia, PA. Dr. Marini will be a featured speaker for the National Vaccine Information Center's First International Public Conference on Vaccination September 13-15 in Alexandria, VA.
Saturday, September 6, 2008
Gardasil®
I have been telling the parents of my teenage patients to be wary of Gardasil® ever since its maker, Merck, tried to strong arm the Texas legislators to mandate it two year ago. My concerns about its safety proved to be warranted. A recent report published by Judicial Watch has summarized the approval process, side effects, safety concerns, and marketing practices related to the human papillomavirus (HPV) vaccine Gardasil based on records obtained under a May 2007 Freedom of Information Act (FOIA). The organization calls the approval of Gardasil as a vaccine as a “large-scale public health experiment.” Here are some of the report’s findings:·
78 cases of outbreaks of warts following the vaccine in women already infected without knowing it. Besides genital warts, some patients experienced massive outbreaks on the face, hands, or feet, sometimes caused by strains not included in the vaccine.·
The vaccine increases the incidence of CIN 2/3 (cervical endothelial neoplasia in moderate stage) in women who had persistent infection with “vaccine-relevant” HPV strains at baseline. · A chart in a report of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) showed an efficacy rate of –44.6% (that’s a minus sign) in subjects already exposed to “relevant HPV types.”·
Most tests with Gardasil were done against an adjuvant-containing “placebo,” rather than a nonreactive saline base, possibly making the vaccine appear safer than it actually is.· It reported that 27% of pregnant women experienced an adverse reaction upon receiving the vaccine, and the Vaccine Adverse Event Reporting System (VAERS) contains 45 cases of spontaneous abortion following Gardasil.·
A total of 8,864 VAERS reports have been filed, including 38 of Guillain-Barre syndrome and 18 deaths, 11 occurring within one week of receiving the vaccine. Association, of course, does not prove causality.
Diane Harper, M.D., a principal chief investigator in clinical HPV trials, was quoted in a Medscape article as saying, “The side effects that have been reported are real and they cannot be brushed aside.” She suggested that physicians not vaccinate patients with personal or family histories of the more serious complications, which have included neurologic disorders, thromboembolism, and autoimmune conditions.
Gynecologist Christiane Northrup, M.D., said on an Oprah show that she wouldn’t advocate vaccinating her daughters, and that medical dollars were better spent elsewhere. Of course her view is opposed by many vaccine front groups masquerading as consumer advocacy such as the National Cervical Cancer and HPV Coalition. In addition to that, The FDA and CDC issued a joint statement reassuring the public and physicians of the vaccine’s safety.
Saturday, August 30, 2008
Vaccines and Autism and Some Research Articles
Legal information on the Hannah Poling case.
CBS reports that nine other autism cases have been settled and sealed, but the parents have gone public in this case.
See CBS report on the case.
Dr. Poling, Hannah's father, has already gone on record defending vaccinations, confounding his critics who want to label him a fanatic.
Dr. Poling's defense of vaccination.
Dr. Poling has also responded to his uninformed medical critics by opening his daughter's case up to public scrutiny and answering any possible criticism.
Dr. Poling rebuts his medical critics.
The medical community is clear that none of the science has changed, but that is secondary because the possibility of liability has changed. If parents can win in court, then the medical community will follow the lead of the courts by changing the way that vaccinations are treated.
Dr. Poling is quotes the CDC policy line that “vaccinations are the most important medical discovery in the last 100 years,” which completely ignores the discovery of antibiotics, etc. But he is clear that parents should question and possibly refuse vaccinations.
The safety record for vaccinations is incredibly hard to find and almost impossible to estimate now that we are using multiple vaccinations. I have listed some information under the vaccinations page. Previously the CDC did give some estimates, but that information was removed and the VAERS reporting site is impossible to interpret.
Mitochondrial disorders such as what Dr. Poling describes for Hannah are more common than has been reported in the media. Her specific mutation is incredibly rare, but I have seen estimates as high as 1 in 500 children for general mitochondrial dysfunction.
In summary: just as non-autistic children can benefit from a good diet (by which I mean something dramatically different from the S.A.D., or Standard American Diet), studies indicate that diet plays a profound role in the brain development of autistic children.
Aliment Pharmacol Ther. 2002 Apr;16(4):663-74. Related Articles, Links
Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands.
Wakefield AJ, Puleston JM, Montgomery SM, Anthony A, O'Leary JJ, Murch SH.
Inflammatory Bowel Disease Study Group, Centre for Gastroenterology, Department of Medicine, Royal Free and University College Medical School, London, UK. wakers@aol.com
There is growing awareness that primary gastrointestinal pathology may play an important role in the inception and clinical expression of some childhood developmental disorders, including autism. In addition to frequent gastrointestinal symptoms, children with autism often manifest complex biochemical and immunological abnormalities. The gut-brain axis is central to certain encephalopathies of extra-cranial origin, hepatic encephalopathy being the best characterized. Commonalities in the clinical characteristics of hepatic encephalopathy and a form of autism associated with developmental regression in an apparently previously normal child, accompanied by immune-mediated gastrointestinal pathology, have led to the proposal that there may be analogous mechanisms of toxic encephalopathy in patients with liver failure and some children with autism. Aberrations in opioid biochemistry are common to these two conditions, and there is evidence that opioid peptides may mediate certain aspects of the respective syndromes. The generation of plausible and testable hypotheses in this area may help to identify new treatment options in encephalopathies of extra-cranial origin. Therapeutic targets for this autistic phenotype may include: modification of diet and entero-colonic microbial milieu in order to reduce toxin substrates, improve nutritional status and modify mucosal immunity; anti-inflammatory/immunomodulatory therapy; and specific treatment of dysmotility, focusing, for example, on the pharmacology of local opioid activity in the gut.
PMID: 11929383 [PubMed - indexed for MEDLINE]
Neuropsychopharmacology 2003 Jan;28(1):193-8 Related Articles, Links
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S.
Autism is a neurodevelopmental disorder characterized by dysfunction in three core behavioral domains: repetitive behaviors, social deficits, and language abnormalities. There is evidence that abnormalities exist in peptide systems, particularly the oxytocin system, in autism spectrum patients. Furthermore, oxytocin and the closely related peptide vasopressin are known to play a role in social and repetitive behaviors. This study examined the impact of oxytocin on repetitive behaviors in 15 adults with autism or Asperger's disorder via randomized double-blind oxytocin and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviors: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant reduction in repetitive behaviors following oxytocin infusion in comparison to placebo infusion. Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion.Neuropsychopharmacology (2003) 28, 193-198. doi:10.1038/sj.npp.1300021
PMID: 12496956 [PubMed - in process]
J Fam Health Care 2002;12(2):34-8 Related Articles, Links
Diet in autism and associated disorders. Garvey J. Royal Free Hospital, London.
A dietitian discusses the theory that peptides with opioid activity may cause or trigger autism. The use of an exclusion diet to treat autism is explained, weighing the potential benefits against some of the practical difficulties of keeping to a strict exclusion diet. The use of nutritional supplements is described. An abnormal gut flora has also been implicated in autism and the use of probiotics and prebiotics in improving the integrity of the gut mucosa is also discussed.
Publication Types:
• Review
• Review, Tutorial
PMID: 12415751 [PubMed - indexed for MEDLINE]
Neuropsychobiology 2002;46(2):76-84 Related Articles, Links
Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder.
Jyonouchi H, Sun S, Itokazu N.
Department of Pediatrics, University of Minnesota, Minneapolis, Minn, USA.
OBJECTIVES: Children with autism spectrum disorder (ASD) frequently reveal various gastrointestinal (GI) symptoms that may resolve with an elimination diet along with apparent improvement of some of the behavioral symptoms. Evidence suggests that ASD may be accompanied by aberrant (inflammatory) innate immune responses. This may predispose ASD children to sensitization to common dietary proteins (DP), leading to GI inflammation and aggravation of some behavioral symptoms. METHODS: We measured IFN-gamma, IL-5, and TNF-alpha production against representative DPs [gliadin, cow's milk protein (CMP), and soy] by peripheral blood mononuclear cells (PBMCs) from ASD and control children [those with DP intolerance (DPI), ASD siblings, and healthy unrelated children]. We evaluated the results in association with proinflammatory and counter-regulatory cytokine production with endotoxin (LPS), a microbial product of intestinal flora and a surrogate stimulant for innate immune responses. RESULTS: ASD PBMCs produced elevated IFN-gamma and TNF-alpha, but not IL-5 with common DPs at high frequency as observed in DPI PBMCs. ASD PBMCs revealed increased proinflammatory cytokine responses with LPS at high frequency with positive correlation between proinflammatory cytokine production with LPS and IFN-gamma and TNF-alpha production against DPs. Such correlation was less evident in DPI PBMCs. CONCLUSION: Immune reactivity to DPs may be associated with apparent DPI and GI inflammation in ASD children that may be partly associated with aberrant innate immune response against endotoxin, a product of the gut bacteria. Copyright 2002 S. Karger AG, Basel
Publication Types:
• Clinical Trial
PMID: 12378124 [PubMed - indexed for MEDLINE]
Nutr Neurosci 2002 Sep;5(4):251-61 Related Articles, Links
A randomised, controlled study of dietary intervention in autistic syndromes.
Knivsberg AM, Reichelt KL, Hoien T, Nodland M.
Center for Reading Research, Stavanger University College, Norway. ann-mari.knivsberg@slf.his.no
Impaired social interaction, communication and imaginative skills characterize autistic syndromes. In these syndromes urinary peptide abnormalities, derived from gluten, gliadin, and casein, are reported. They reflect processes with opioid effect. The aim of this single blind study was to evaluate effect of gluten and casein-free diet for children with autistic syndromes and urinary peptide abnormalities. A randomly selected diet and control group with 10 children in each group participated. Observations and tests were done before and after a period of 1 year. The development for the group of children on diet was significantly better than for the controls.
PMID: 12168688 [PubMed - indexed for MEDLINE]
Nutr Neurosci 2001;4(1):25-37 Related Articles, Links
Reports on dietary intervention in autistic disorders.
Knivsber AM, Reichelt KL, Nodland M.
Center for Reading Research, Stavanger College, Norway. ann-mari.knivsberg@slf.his.no
Autism is a developmental disorder for which no cure currently exists. Gluten and/or casein free diet has been implemented to reduce autistic behaviour, in addition to special education, since early in the eighties. Over the last twelve years various studies on this dietary intervention have been published in addition to anecdotal, parental reports. The scientific studies include both groups of participants as well as single cases, and beneficial results are reported in all, but one study. While some studies are based on urinary peptide abnormalities, others are not. The reported results are, however, more or less identical; reduction of autistic behaviour, increased social and communicative skills, and reappearance of autistic traits after the diet has been broken.
PMID: 11842874 [PubMed - indexed for MEDLINE]
J Autism Dev Disord 2000 Oct;30(5):463-9 Related Articles, Links
Comment in:
• J Autism Dev Disord. 2000 Oct;30(5):471-3.
Metabolic approaches to the treatment of autism spectrum disorders. Page T. Department of Neurosciences, University of California, San Diego, USA.
Although the exact prevalence of metabolic abnormalities in autism spectrum disorders is unknown, several metabolic defects have been associated with autistic symptoms. These include phenylketonuria, histidinemia, adenylosuccinate lyase deficiency, dihydropyrimidine dehydrogenase deficiency, 5'-nucleotidase superactivity, and phosphoribosylpyrophosphate synthetase deficiency. When the metabolic consequences of an enzyme defect are well defined (e.g., phenylketonuria, 5'-nucleotidase superactivity), treatment with diet, drugs, or nutritional supplements may bring about a dramatic reduction in autistic symptoms. This review evaluates evidence for metabolic etiologies in autism spectrum disorders, as well as for the efficacy of dietary and vitamin treatments. The relationship between gastrointestinal abnormalities and autism spectrum disorders is also considered.
PMID: 11098885 [PubMed - indexed for MEDLINE]
Am J Psychiatry 1978 Apr;135(4):472-5 Related Articles, Links
The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study.
Rimland B, Callaway E, Dreyfus P.
The authors used data from an earlier nonblind study to identify 16 autistic-type child outpatients who had apparently improved when given vitamin B6 (pyridoxine). In a double-blind study each child's B6 supplement was replaced during two separate experimental trial periods with either a B6 supplement or a matched placebo. Behavior was rated as deteriorating significantly during the B6 withdrawal.
Publication Types:
• Clinical Trial
• Controlled Clinical Trial
PMID: 345827 [PubMed - indexed for MEDLINE]
By Dr. Mercola